MoviePass Rival Sinemia Shuts Down U.S. Service

Courtesy of Sinemia

The indie movie subscription service cites legal troubles and competing offers from exhibition giants.

Sinemia, a MoviePass competitor well-known in Europe, is shutting down its U.S. movie subscription service.

“Today, with a heavy heart, we’re announcing that Sinemia is closing its doors and ending operations in the U.S., effective immediately,” the moviegoing app said on its homepage. "While we are proud to have created a best-in-market service, our efforts to cover the cost of unexpected legal proceedings and raise the funds required to continue operations have not been sufficient," Sinemia added.

The movie subscription service also cited competition from exhibition giants with their own upstart ticket subscription services. "We are all witnessing that the future of moviegoing is evolving through movie ticket subscriptions. ... However, we didn't see a path to sustainability as an independent movie ticket subscription service in the face of competition from movie theaters as they build their own subscriptions," Sinemia explained.

Cinema subscription plans from bigger chains, like AMC Theaters with its A-List Stubs program and Cinemark's Movie Club, are targeting frequent moviegoers in the U.S. market. Sinemia, which has a far bigger footprint in Europe, has never broken out its number of American subscribers.

The movie app had packaging plans that were billed annually and had no initiation fees or monthly plans that included sign-up fees.

Like MoviePass, Sinemia paid full price for tickets and attempted to make money by marketing film titles to users and selling other advertising.

A rep for Sinemia declined to comment beyond the website statement.